Midlife weight gain is a persistent challenge for many women, but emerging research suggests hormone therapy may enhance response to glucagon-like peptide-1 (GLP-1)–based treatments.

Treating vasomotor symptoms, sleep disturbance, and mood disorders can remove barriers to weight loss for women during menopause, experts say.

Regardless of how much weight you lose, GLP-1 drugs like Wegovy and Ozempic could decrease major adverse cardiovascular events.

An analysis found that a shrinking waist size was responsible for only around a third of the cardiovascular benefits in ...

Magnesium may be helpful for weight loss. It plays an important role in appetite control, energy metabolism, and blood sugar ...

MariTide is now progressing into phase 3 trials, with a focus on its long-term safety and efficacy. Amgen expects to apply ...

GLP-1 weight loss medications: Providers can prescribe brand-name GLP-1 agonist medications, including Wegovy and Zepbound, ...

Canadiens rebounded with a 5–1 win over Detroit after a frustrating loss to Toronto. Lane Hutson took responsibility for previous mistakes: “It’s on me... I need to be better.” Coach St. Louis praised ...

ABC News' Juju Chang investigates the digital market for counterfeit weight-loss medications, as well as the warning signs to ...

Sadly, it’s probably going to take more than celebrity endorsement to change the way society views people who are overweight.

Zepbound (tirzepatide) and Wegovy (semaglutide) are FDA-approved injectable medications revolutionizing weight management. Both belong to the incretin mimetic drug class but differ in their mechanisms ...

I was waiting in line to enter the church for the funeral. I couldn’t believe he was even having one... A church funeral? The only times I ever remembered him going were Christmas Eve or Easter, but ...